Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Plauchu

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2011
Ex vivo study of bevacizumab transport through porcine nasal mucosaGéraldine Samson, Alicia García de la Calera, Sophie Dupuis-Girod, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patientsGaetan Lesca, Emmanuelle Genin, Claire Blachier, et al.
European Journal of Human Genetics : EJHG|June 29, 2012
Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndromeBarbara Kloeckener-Gruissem, John Neidhardt, István Magyar, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological InsightsJérôme Dumortier, Sophie Dupuis-Girod, Pierre-Jean Valette, et al.
European Journal of Human Genetics : EJHG|January 15, 2004
Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entityPhilippe Khau Van Kien, Jean-Eric Wolf, Flavie Mathieu, et al.
Human Mutation|May 18, 2006
Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patientsGaëtan Lesca, Nelly Burnichon, Grégory Raux, et al.
Human Mutation|March 17, 2004
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in FranceGaëtan Lesca, Henri Plauchu, Florence Coulet, et al.
Archives of Cardiovascular Diseases|July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndromeDelphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Virchows Archiv : an International Journal of Pathology|May 3, 2012
Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers-Danlos syndromeKim-Thanh Ong, Henri Plauchu, Simone Peyrol, et al.
Lancet (London, England)|September 10, 2010
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trialKim-Thanh Ong, Jérôme Perdu, Julie De Backer, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2011
Ex vivo study of bevacizumab transport through porcine nasal mucosaGéraldine Samson, Alicia García de la Calera, Sophie Dupuis-Girod, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patientsGaetan Lesca, Emmanuelle Genin, Claire Blachier, et al.
European Journal of Human Genetics : EJHG|June 29, 2012
Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndromeBarbara Kloeckener-Gruissem, John Neidhardt, István Magyar, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological InsightsJérôme Dumortier, Sophie Dupuis-Girod, Pierre-Jean Valette, et al.
European Journal of Human Genetics : EJHG|January 15, 2004
Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entityPhilippe Khau Van Kien, Jean-Eric Wolf, Flavie Mathieu, et al.
Human Mutation|May 18, 2006
Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patientsGaëtan Lesca, Nelly Burnichon, Grégory Raux, et al.
Human Mutation|March 17, 2004
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in FranceGaëtan Lesca, Henri Plauchu, Florence Coulet, et al.
Archives of Cardiovascular Diseases|July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndromeDelphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Virchows Archiv : an International Journal of Pathology|May 3, 2012
Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers-Danlos syndromeKim-Thanh Ong, Henri Plauchu, Simone Peyrol, et al.
Lancet (London, England)|September 10, 2010
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trialKim-Thanh Ong, Jérôme Perdu, Julie De Backer, et al.
Pageof 4